ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 104

The Usefulness of A NEW Musculoskeletal ULTRASOUND  Scoring System of the Hands and Wrist Joints (US10)  for Evaluation of EARLY Rheumatoid Arthritis Patients

Karine R. Luz, Rita N.V. Furtado, Marcelo M. Pinheiro, Giovanna S. Petterle and Jamil Natour, Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: diagnosis, rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose: Ultrasound (US) can be a useful tool for monitoring rheumatoid arthritis (RA). However, it can be time consuming when applied to too many joints as there is lack of uniformly standardised scoring system. Thus the aim of the present study was to propose a new US score of the hands and wrist joints (US10) and to evaluate its correlation with clinical, laboratory and functional status during a 48-weeks follow-up.

Methods: Forty-eight early RA patients with less-than-1 year symptom with no previous use of disease-modifying antirheumatic drugs (DMARD) were enrolled on the study. The patients underwent clinical, laboratory assessment and blinded US examination at baseline, 3, 6, 9 and 12 months. The US10 included the following joints: wrist, second and third metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. This score was composed by the following 10 parameters,  according to inflammation:qualitative (0-1;range of 0–16) and semi-quantitative(0-3; range of 0–48) scoring to synovial proliferation(SPQ10,SPSQ10) and to power Doppler (PD) (PDQ10,PDSQ10), and qualitative (0-1) gray scale and PD scores for tenosynovitis/paratendinosis (GSTN10, PDTN, range of 0–10). A second US finding was categorised according to joint damage: a qualitative (0-1) and semi-quantitative(0-3) scoring to bone erosions (ERQ10, range of 0–12; ERSQ10, range of 0–36) and to cartilage damage (CAQ10, range of 0–4; CASQ10, range of 0–12). The following were clinical and laboratory assessments: C-reactive protein level(CRP), 28-joint Disease Activity Score (DAS 28) and Health Assessment Questionnaire (HAQ). All patients were treated with the same protocol of treatment and by just one rheumatologist.

Results: The mean ± duration of the symptoms was 7,58 ( ± 3,59) months. All patients had high activity disease with mean ± DAS 28 of 6,50 ( ± 1,29). At baseline, there was significant correlation between all US parameters for inflammation (p<0,05) and the US parameters for joint damage (ERQ10, ERSQ10 and CASQ10) also had a good significant correlation (p<0,05)with synovial proliferation parameters. Besides, significant correlation (p<0,05) between all the US10 parameters for inflammation and CRP was observed. In addition, the PD and tenosynovitis scores showed a significant correlation (p<0,05) with DAS28. Longitudinal changes through out 12 months for the inflammation parameters (SPQ10, SPSQ10, GSTN and PDTN) and for bone erosions scores showed a highly significant correlation (p<0,05). There was a significant correlation between changes in the US parameters for synovial proliferation for tenosynovitis and the DAS28 changes(SPQ10/DAS28:r=0,33,p<0,05;SPSQ10/DAS28:r=0,30,p<0,05;TNQ10/DAS28:r=0,48,p<0,05;TNQPD10:r=0,48,p<0,48) in a 12-month period. After one year, there was also a significant correlation between changes in the inflammation scores, in the CRP and in HAQ. 

Conclusion: A new US scoring system of hand and wrist joints (US10) seemed to be a useful tool to monitor inflammation and joint damage in early RA patients with a significant correlation to longitudinal changes of disease activity criteria.


Disclosure:

K. R. Luz,
None;

R. N. V. Furtado,
None;

M. M. Pinheiro,
None;

G. S. Petterle,
None;

J. Natour,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-usefulness-of-a-new-musculoskeletal-ultrasound-scoring-system-of-the-hands-and-wrist-joints-us10-for-evaluation-of-early-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology